Precision for Medicine acquires Redwood Outcomes, a Canadian HEOR firm
Acquisition adds more expertise in epidemiology and patient outcomes analysis
Precision for Value, a unit of New York-based Precision for Medicine, is adding Redwood Outcomes, based in Vancouver, BC to its stable. Earlier this year, the company had acquired Precision Health Economics (PHE); Redwood will be managed as a subsidiary of PHE, says the company.
Precision for Medicine itself comes together as a group of consulting organization and service providers, mostly for pharma clients: Hobart Group Holdings, Core Access Group, and PHE. The company has 10 offices (now 14, presuming the Vancouver office will remain open), and operates both in the US and in Europe. It specializes in market access issues, payer and managed markets research and promotion, health outcomes and contract administration.
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.
